RVMD Revolution Medicines, Inc. - Common Stock
$152.39
Price · May 20, 2026
52W Range
$34–$156
97% of range
Analyst Rating
BUY
27 analysts
Price Target
$181
+19% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
RVMD Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$152.38
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$34 – $156
RVMD Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
RVMD
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
RVMD
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
RVMD
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
RVMD
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
RVMD
Peer Median
RVMD Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
27 analysts
- Strong Buy 11 40.7%
- Buy 15 55.6%
- Hold 1 3.7%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
20 analysts · 2026-05-17
Median
$175.00
Now
$152.38
Low
$116.00
High
$263.00
Median target
$175.00
+14.8%
Mean target
$181.30
+19.0%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.20%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-2.29 | $-1.88 | -0.41% |
| Dec. 31, 2025 | $-1.86 | $-1.61 | -0.25% |
| Sept. 30, 2025 | $-1.61 | $-1.45 | -0.16% |
| June 30, 2025 | $-1.31 | $-1.16 | -0.15% |
| March 31, 2025 | $-1.13 | $-1.11 | -0.02% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| RVMD | — | — | — | — | — | — |
| GILD | $152.32B | 18.1 | 2.4% | 28.9% | 40.5% | — |
| VRTX | $115.15B | 29.6 | 8.9% | 32.9% | 22.1% | — |
| REGN | $106.21B | 18.6 | 0.99% | 31.4% | 14.7% | — |
| ALNY | $52.64B | 170.7 | 65.2% | 8.5% | 60.4% | — |
| NTRA | $32.00B | -150.7 | 35.9% | -9.0% | -14.1% | — |
| BIIB | $25.84B | 20.0 | 2.2% | 13.1% | 7.2% | — |
| UTHR | $21.27B | 17.5 | 10.6% | 41.9% | 18.7% | 87.9% |
| INSM | $37.29B | -27.1 | 66.7% | -210.5% | -128.4% | — |
| INCY | $19.60B | 15.4 | 21.2% | 25.0% | 27.6% | — |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.